LXR

LXR(肝脏 X 受体 α 和 β)是核激素受体超家族的配体激活转录因子成员。LXR 是氧固醇激活的转录因子,可上调一组基因,这些基因共同促进细胞和体内过量胆固醇的协调调动。与其他核受体一样,LXR 具有抗炎作用,可抑制核因子 κB、激活蛋白 1 和其他转录因子对促炎基因的信号依赖性诱导。

LXRα 主要表达于某些组织,包括肝脏、肾脏、巨噬细胞和脂肪组织。然而,LXRβ 则普遍表达。激活 LXRα(主要在肝脏中表达)会导致高甘油三酯生成,越来越多的证据表明,选择性 LXRβ 激动剂可以减少这种副作用。

LXRs (Liver X Receptor α and β) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors. LXRs are oxysterol-activated transcription factors that upregulate a suite of genes that together promote coordinated mobilization of excess cholesterol from cells and from the body. The LXRs, like other nuclear receptors, are anti-inflammatory, inhibiting signal-dependent induction of pro-inflammatory genes by nuclear factor-κB, activating protein-1, and other transcription factors.

LXRα is expressed predominately in some tissues, including the liver, kidney, macrophages, and adipose tissue. However, LXRβ is ubiquitously expressed. Activating LXRα (mainly expressed in liver) results in high triglyceride production, and growing evidence suggests that selective LXRβ agonists can reduce this side effect.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Rohitukine
罗希吐碱

Rohitukine 是一种具有口服活性的 CDK9/T1 抑制剂(IC50 为 0.3 μM),可阻断 Cdk2/A 和 Cdk9/T1 的 ATP 结合位点,抑制 PPARγ、AKT、mTOR、C/EBPα、SREBP-2 和 NF-κB 信号通路,并上调肝脏 LXRα 的表达,同时可诱导细胞周期 S 期阻滞、ROS 生成和细胞凋亡 (apoptosis),且具有抗炎活性,可用于白血病、胰腺癌、前列腺癌、乳腺癌、中枢神经系统癌症、卵巢癌、肺癌、血脂异常、炎症性疾病、炎症性肠病及关节炎的研究。

71294-60-5
Inducer
罗希吐碱

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础